Advertisement
Screener

Exelixis Inc (EXEL) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

EXELIXIS, INC. Return Tang Equity

Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • EXELIXIS, INC. return tang equity for the quarter ending 2026-07-03 was 48.35%, a 58.12% increase year-over-year.
  • EXELIXIS, INC. return tang equity for the quarter ending 2026-04-03 was 44.52%, a 43.01% increase year-over-year.
  • EXELIXIS, INC. return tang equity for the quarter ending 2026-01-02 was 37.31%, a 56.06% increase year-over-year.
  • EXELIXIS, INC. return tang equity for the quarter ending 2025-10-03 was 32.33%, a 53.13% increase year-over-year.
  • EXELIXIS, INC. return tang equity for fiscal 2026 was 37.31%, a 56.06% increase from fiscal 2025.
  • EXELIXIS, INC. return tang equity for fiscal 2025 was 23.91%, a 153.16% increase from fiscal 2023.
  • EXELIXIS, INC. return tang equity for fiscal 2023 was 9.44%, a 25.61% increase from fiscal 2022.
  • EXELIXIS, INC. return tang equity for fiscal 2022 was 7.52%, a 30.15% decline from fiscal 2021.
Available history
2009-12-31 to 2026-07-03
Data captured

Historical Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2026-07-0348.35%$860.62M$1.78B
2026-04-0344.52%$833.42M$1.87B
2026-01-0237.31%$782.57M$2.1B
2025-10-0332.33%$677.9M$2.1B
2025-07-0430.58%$602.3M$1.97B
2025-04-0431.13%$643.57M$2.07B
2025-01-0323.91%$521.27M$2.18B
2024-09-2721.11%$466.92M$2.21B
2024-06-2817.02%$349.99M$2.06B
2024-03-299.93%$205.05M$2.06B
2023-12-299.44%$207.77M$2.2B
2023-09-294.03%$92.07M$2.28B
2023-06-306.67%$164.24M$2.46B
2023-03-316.17%$153.74M$2.49B
2022-12-307.52%$182.28M$2.42B
2022-09-3012.67%$307.62M$2.43B
2022-07-0111.71%$272.62M$2.33B
2022-04-0113.36%$298.04M$2.23B
2021-12-3110.76%$231.06M$2.15B
2021-10-018.02%$164.29M$2.05B
2021-07-024.75%$94.04M$1.98B
2021-04-023.51%$64.77M$1.85B
2021-01-016.16%$111.78M$1.82B
2020-10-028.51%$152.14M$1.79B
2020-07-0315.91%$281.63M$1.77B
2020-04-0317.45%$293.85M$1.68B
2020-01-0319.79%$321.01M$1.62B
2019-09-2739.76%$612.36M$1.54B
2019-06-2845.02%$641.54M$1.42B
2019-03-2949.19%$649.99M$1.32B
2018-12-2856.39%$690.07M$1.22B
2018-09-2843.23%$368.47M$852.28M
2018-06-2945.43%$323.22M$711.52M
2017-06-3068.60%$58.2M$84.83M
2017-03-3110.17%$5.7M$56.07M
2016-12-31-273.94%-$70.22M$25.63M
2016-09-30464.00%-$146.91M-$31.66M
2016-06-3072.52%-$181.17M-$249.82M
2016-03-3186.37%-$189.7M-$219.64M
2015-12-3181.00%-$165.64M-$204.49M
2015-09-30126.73%-$174.78M-$137.91M
2015-06-3076.15%-$191.8M-$251.87M
2015-03-31105.42%-$221.85M-$210.44M
2014-12-31117.17%-$261.3M-$223.01M
2014-09-30224.86%-$274.77M-$122.2M
2014-06-30462.15%-$279.33M-$60.44M
2014-03-31-3437.83%-$268.08M$7.8M
2013-12-31484.27%-$238.19M-$49.19M
2013-09-30-324.12%-$223.9M$69.08M
2013-06-30-142.92%-$189.59M$132.65M
2013-03-31-85.74%-$163.91M$191.17M
2012-12-31-83.31%-$145.34M$174.44M
2012-09-30-17.74%-$49.16M$277.16M
2012-06-30173.97%$61.52M$35.37M
2012-03-31112.19%$77.04M$68.67M
2011-12-31280.90%$75.7M$26.95M
2011-09-30-19.03%$11.54M-$60.63M
2011-06-3051.50%-$74.93M-$145.5M

Annual Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2026-01-0237.31%$782.57M$2.1B
2025-01-0323.91%$521.27M$2.18B
2023-12-299.44%$207.77M$2.2B
2022-12-307.52%$182.28M$2.42B
2021-12-3110.76%$231.06M$2.15B
2021-01-016.16%$111.78M$1.82B
2020-01-0319.79%$321.01M$1.62B
2018-12-2856.39%$690.07M$1.22B
2017-12-2969.70%$154.23M$221.28M
2016-12-31-273.94%-$70.22M$25.63M
2016-12-30-273.94%-$70.22M$25.63M
2016-01-0179.10%-$161.74M-$204.49M
2015-12-3179.10%-$161.74M-$204.49M
2014-12-31117.17%-$261.3M-$223.01M
2013-12-31484.27%-$238.19M-$49.19M
2012-12-31-83.31%-$145.34M$174.44M
2011-12-31280.90%$75.7M$26.95M
2010-12-3131.62%-$92.33M-$292.01M
2009-12-3182.59%-$135.22M-$163.73M

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78